NANOCOATINGS MARKET ANALYSIS

Nanocoatings MarketSize and Trends

Nanocoatings involves the nanotechnology coatings that offer superior properties such as better abrasion resistance, hardness, transparency ductility, and lubricity compared to conventional coatings. Moreover, they have low VOC emissions which makes them preferable for various range of eco-friendly applications. Antimicrobial, anti-fingerprint, easy-to-clean & anti-fouling, self-cleaning (bionic & Photocatalytic) are some of the major types of Nanocoatings.

The global nanocoatings market is estimated to be valued at US$ 10,511.1 million in 2021 and is expected to exhibit a CAGR of 24.7 % over the forecast period (2021-2028).

Figure 1. Global Nanocoatings Market Value (US$ Mn), by Region, 2020

Key Takeaways of the Graph:

• The Anti-microbial segment in product type held dominant position in the market and accounted for 29.93% share in the global nanocoatings market in 2020. The segment is expected to reach US$ 15,096.0 million in 2028.
• Anti-microbial coatings are majorly used in the food manufacturing, water treatment, building & construction, packaging, and medical & healthcare sectors to avoid the spread of harmful microbes.

Figure 2. Global Nanocoatings Market Share, By Product type, 2020

Market Trends

Anti-fouling & easy-to-clean coatings are gaining popularity from automotive, marine, electronics, and food manufacturing applications. Moreover, these nanocoatings also restrict the growth of fungal and algae. Anti-fingerprint coatings are also expected to gain significant growth from medical & healthcare and electronics applications. Moreover, self-cleaning nanotechnology is also projected to foster the market growth of the nanotechnology over the forecast period.

Growing strategic partnerships and agreements between key manufacturers for expanding the business presence is one of the emerging trends in the market. For instance, in January 2020, Proximo Medical enter into a partnership with CeloNova Biosciences, supplier of the COBRA PzF nanocoated coronary stent (NCS), in the US markets. CeloNova Biosciences is a global medical device company that offers products based upon its proprietary Polyzene-F NanoCoating technology.